BridgeBio Pharma, Inc.
NASDAQ: BBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Neil Kumar
- Employees
- 725
- Headquarters
- Palo Alto, United States
- IPO year
- 2019
- Market cap
- $13.0B
- Website
- https://www.bridgebio.com
Loading BBIO…
Loading profile data…Frequently asked questions about BBIO
What does BridgeBio Pharma, Inc. (BBIO) do?
BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable cand...
Where does BBIO trade?
BridgeBio Pharma, Inc. (BBIO) trades on the NASDAQ Global Select.
What sector is BBIO in?
BridgeBio Pharma, Inc. (BBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BridgeBio Pharma, Inc.?
Neil Kumar is the chief executive officer of BridgeBio Pharma, Inc. (BBIO).
Where is BridgeBio Pharma, Inc. headquartered?
BridgeBio Pharma, Inc. is headquartered in United States.
Does BBIO pay a dividend?
BridgeBio Pharma, Inc. (BBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BBIO go public?
BridgeBio Pharma, Inc. (BBIO) completed its initial public offering in 2019.